Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Diakonos Oncology Corp.

Diakonos Oncology Appoints Laura Aguilar, M.D., Ph.D. as Chief Medical Officer
From Diakonos Oncology Corp.
Via Business Wire
Neurosurgeon Joseph Georges, P.I. for Diakonos Oncology’s Phase 1 Trial of Its Unique Dendritic Cell Vaccine for Gliobastoma, Receives the CNS 2024 Rosenblum-Mahaley Clinical Research Award
From Diakonos Oncology Corp.
Via Business Wire
CNS 2024 Conference Presentation: Diakonos Oncology’s Autologous Dendritic Cell Vaccine (DOC1021) Yields 93% 12-Month Survival for Glioblastoma Patients
From Diakonos Oncology Corp.
Via Business Wire
Diakonos Oncology Announces Final Closing of Oversubscribed $11.4M Seed Financing to Advance Its Highly Differentiated Dendritic Cell Vaccine (DOC1021) into a Phase 2 Clinical Trial
From Diakonos Oncology Corp.
Via Business Wire
Diakonos Oncology CFO Anthony Baldor to Provide Corporate Update at BIO International Convention In San Diego, June 3 - 6, 2024
From Diakonos Oncology Corp.
Via Business Wire
Diakonos Oncology’s Unique Dendritic Cell Vaccine (DOC1021) Improves Survival Compared to Standard of Care in Phase 1 Trial for Glioblastoma
From Diakonos Oncology Corp.
Via Business Wire
Diakonos Oncology Appoints Biotech Veteran Anthony Baldor as Chief Financial Officer
From Diakonos Oncology Corp.
Via Business Wire
Diakonos Oncology Names Paul Lammers, M.D., Veteran BioPharma Senior Executive, to its Board of Directors
From Diakonos Oncology Corp.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.